BACKGROUND: Recent attempts to standardise the definition of Mild Cognitive Impairment (MCI) in Parkinson's disease (PD) by the Movement Disorder Society Task Force has led to a greater understanding of this entity but to date, there has been a paucity of research regarding the impact of PD-MCI on caregiver outcomes. OBJECTIVE: The aim of this study was to utilise the newly established PD-MCI diagnostic criteria to investigate caregiver outcomes in relation to four specific aspects: (1) caregiver burden, (2) quality of life (QoL), (3) caregiving experience, and (4) psychological distress. METHODS: This study included a total of 166 patient-caregiver dyads. Caregiver outcomes including quality of life, caregiver burden, mood disturbances, and caregiver experience were compared between caregivers of PD patients classified as having normal cognition (PD-NC) and PD-MCI. RESULTS: Despite the two groups being matched on demographic and clinical features, caregivers of PD-MCI patients reported a lower level of QoL with regard to physical health and more interruptions with usual activities. On the other hand, a higher impact on finances was reported in caregivers of PD-NC patients, relative to caregivers of PD-MCI patients. CONCLUSIONS: This study has shown that even at earlier stages of cognitive impairment, PD-MCI caregivers already experience elevated levels of distress in the role of providing care to their care-recipients. These findings highlight the need to include management of caregiver distress and associated sequelae alongside the management of PD-MCI patients, early on in the disease course.
BACKGROUND: Recent attempts to standardise the definition of Mild Cognitive Impairment (MCI) in Parkinson's disease (PD) by the Movement Disorder Society Task Force has led to a greater understanding of this entity but to date, there has been a paucity of research regarding the impact of PD-MCI on caregiver outcomes. OBJECTIVE: The aim of this study was to utilise the newly established PD-MCI diagnostic criteria to investigate caregiver outcomes in relation to four specific aspects: (1) caregiver burden, (2) quality of life (QoL), (3) caregiving experience, and (4) psychological distress. METHODS: This study included a total of 166 patient-caregiver dyads. Caregiver outcomes including quality of life, caregiver burden, mood disturbances, and caregiver experience were compared between caregivers of PD patients classified as having normal cognition (PD-NC) and PD-MCI. RESULTS: Despite the two groups being matched on demographic and clinical features, caregivers of PD-MCIpatients reported a lower level of QoL with regard to physical health and more interruptions with usual activities. On the other hand, a higher impact on finances was reported in caregivers of PD-NCpatients, relative to caregivers of PD-MCIpatients. CONCLUSIONS: This study has shown that even at earlier stages of cognitive impairment, PD-MCI caregivers already experience elevated levels of distress in the role of providing care to their care-recipients. These findings highlight the need to include management of caregiver distress and associated sequelae alongside the management of PD-MCIpatients, early on in the disease course.
Entities:
Keywords:
Mild cognitive impairment; Parkinson’s disease; caregiver burden; caregiver outcomes; quality of life
Authors: Noelle E Carlozzi; Carey W Sherman; Kaley Angers; Mitchell P Belanger; Amy M Austin; Kelly A Ryan Journal: Aging Ment Health Date: 2017-07-12 Impact factor: 3.658
Authors: Ann J Jones; Roeline G Kuijer; Leslie Livingston; Daniel Myall; Kyla Horne; Michael MacAskill; Toni Pitcher; Paul T Barrett; Tim J Anderson; John C Dalrymple-Alford Journal: Transl Neurodegener Date: 2017-06-19 Impact factor: 8.014
Authors: Annie C Lajoie; Joelle Crane; Ann R Robinson; Anne-Louise Lafontaine; Andrea Benedetti; R John Kimoff; Marta Kaminska Journal: Trials Date: 2021-12-11 Impact factor: 2.279
Authors: Nadeeka N Dissanayaka; Elana J Forbes; Ji Hyun J Yang; Dana Pourzinal; John D O'Sullivan; Leander K Mitchell; David A Copland; Katie L McMahon; Gerard J Byrne Journal: J Neurol Date: 2021-08-04 Impact factor: 4.849